BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15614786)

  • 1. Stimulation of G-proteins in human control and Alzheimer's disease brain by FAD mutants of APP(714-723): implication of oxidative mechanisms.
    Karelson E; Fernaeus S; Reis K; Bogdanovic N; Land T
    J Neurosci Res; 2005 Feb; 79(3):368-74. PubMed ID: 15614786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of methionine-722 in the stimulation of human brain G-proteins and neurotoxicity induced by London familial Alzheimer's disease (FAD) mutated V717G-APP(714-723).
    Reis K; Zharkovsky A; Bogdanovic N; Karelson E; Land T
    Neuroscience; 2007 Jan; 144(2):571-8. PubMed ID: 17101228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 17beta-Oestradiol stimulation of G-proteins in aged and Alzheimer's human brain: comparison with phytoestrogens.
    Jefremov V; Rakitin A; Mahlapuu R; Zilmer K; Bogdanovic N; Zilmer M; Karelson E
    J Neuroendocrinol; 2008 May; 20(5):587-96. PubMed ID: 18363809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
    Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
    J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid precursor protein carboxy-terminal fragments modulate G-proteins and adenylate cyclase activity in Alzheimer's disease brain.
    Mahlapuu R; Viht K; Balaspiri L; Bogdanovic N; Saar K; Soomets U; Land T; Zilmer M; Karelson E; Langel U
    Brain Res Mol Brain Res; 2003 Sep; 117(1):73-82. PubMed ID: 14499483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of amyloid precursor protein is associated with degeneration, decreased viability, and increased damage caused by neurotoxins (prostaglandins A1 and E2, hydrogen peroxide, and nitric oxide) in differentiated neuroblastoma cells.
    Hanson AJ; Prasad JE; Nahreini P; Andreatta C; Kumar B; Yan XD; Prasad KN
    J Neurosci Res; 2003 Oct; 74(1):148-59. PubMed ID: 13130517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain G protein-dependent signaling pathways in Down syndrome and Alzheimer's disease.
    Lumbreras M; Baamonde C; Martínez-Cué C; Lubec G; Cairns N; Sallés J; Dierssen M; Flórez J
    Amino Acids; 2006 Nov; 31(4):449-56. PubMed ID: 16583316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
    Sóvágó J; Makkai B; Gulyás B; Hall H
    Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT1A receptor-mediated G protein activation assessed by [35S]GTPgammaS binding in rat cerebral cortex.
    Odagaki Y; Toyoshima R
    Eur J Pharmacol; 2005 Oct; 521(1-3):49-58. PubMed ID: 16182280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer amyloid protein precursor complexes with brain GTP-binding protein G(o).
    Nishimoto I; Okamoto T; Matsuura Y; Takahashi S; Okamoto T; Murayama Y; Ogata E
    Nature; 1993 Mar; 362(6415):75-9. PubMed ID: 8446172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease.
    Vaisid T; Kosower NS; Katzav A; Chapman J; Barnoy S
    Neurochem Int; 2007; 51(6-7):391-7. PubMed ID: 17513017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric modulation of adenosine A1 receptor coupling to G-proteins in brain.
    Childers SR; Li X; Xiao R; Eisenach JC
    J Neurochem; 2005 May; 93(3):715-23. PubMed ID: 15836630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
    Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
    J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrinsic signaling function of APP as a novel target of three V642 mutations linked to familial Alzheimer's disease.
    Okamoto T; Takeda S; Giambarella U; Murayama Y; Matsui T; Katada T; Matsuura Y; Nishimoto I
    EMBO J; 1996 Aug; 15(15):3769-77. PubMed ID: 8670881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid-beta precursor protein mediates neuronal toxicity of amyloid beta through Go protein activation.
    Sola Vigo F; Kedikian G; Heredia L; Heredia F; Añel AD; Rosa AL; Lorenzo A
    Neurobiol Aging; 2009 Sep; 30(9):1379-92. PubMed ID: 18187234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
    Abdul HM; Calabrese V; Calvani M; Butterfield DA
    J Neurosci Res; 2006 Aug; 84(2):398-408. PubMed ID: 16634066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial oxidative stress index, activity of redox-sensitive aconitase and effects of endogenous anti- and pro-oxidants on its activity in control, Alzheimer's disease and Swedish Familial Alzheimer's disease brain.
    Raukas M; Rebane R; Mahlapuu R; Jefremov V; Zilmer K; Karelson E; Bogdanovic N; Zilmer M
    Free Radic Res; 2012 Dec; 46(12):1490-5. PubMed ID: 22962855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in regional and subcellular localization of G(q/11) and RGS4 protein levels in Alzheimer's disease: correlation with muscarinic M1 receptor binding parameters.
    Muma NA; Mariyappa R; Williams K; Lee JM
    Synapse; 2003 Jan; 47(1):58-65. PubMed ID: 12422374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
    Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
    Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons.
    Melo JB; Sousa C; Garção P; Oliveira CR; Agostinho P
    Eur J Neurosci; 2009 Feb; 29(3):455-64. PubMed ID: 19222556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.